BioVie Inc. announced on October 28, 2024, the pricing of a registered direct offering of 1,146,000 shares of its common stock. The shares were priced at-the-market under Nasdaq rules at $2.83 per share.
This offering is expected to result in total gross proceeds of approximately $3.2 million, before deducting placement agent fees and offering expenses. The company intends to use the net proceeds primarily for working capital and general corporate purposes.
The registered direct offering is anticipated to close on or about October 29, 2024, subject to the satisfaction of customary closing conditions. ThinkEquity is acting as the sole placement agent for this offering.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.